Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats

Neuroscience
Yi PangLir-Wan Fan

Abstract

Protection of substantia nigra (SN) dopaminergic (DA) neurons by neurotrophic factors (NTFs) is one of the promising strategies in Parkinson's disease (PD) therapy. A major clinical challenge for NTF-based therapy is that NTFs need to be delivered into the brain via invasive means, which often shows limited delivery efficiency. The nose to brain pathway is a non-invasive brain drug delivery approach developed in recent years. Of particular interest is the finding that intranasal insulin improves cognitive functions in Alzheimer's patients. In vitro, insulin has been shown to protect neurons against various insults. Therefore, the current study was designed to test whether intranasal insulin could afford neuroprotection in the 6-hydroxydopamine (6-OHDA)-based rat PD model. 6-OHDA was injected into the right side of striatum to induce a progressive DA neuronal lesion in the ipsilateral SN pars compact (SNc). Recombinant human insulin was applied intranasally to rats starting from 24h post lesion, once per day, for 2 weeks. A battery of motor behavioral tests was conducted on day 8 and 15. The number of DA neurons in the SNc was estimated by stereological counting. Our results showed that 6-OHDA injection led to significant motor ...Continue Reading

References

Jun 12, 2004·Endocrinology·Marc G JeschkeRalf Einspanier
Aug 4, 2004·Psychoneuroendocrinology·Christian BenedictWerner Kern
Nov 9, 2004·Experimental Neurology·Zaodung LingPaul M Carvey
Jan 20, 2005·Journal of Neural Transmission·S-J Kim, Y Han
Jan 4, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Jordi BovéSerge Przedborski
May 3, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Piotr HadaczekKrystof Bankiewicz
May 22, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·David R MarksDebra A Fadool
Sep 29, 2009·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yildiz OzsoyErdal Cevher
Feb 27, 2010·Developmental Neurobiology·Ignacio Torres-Aleman
Nov 29, 2011·Advanced Drug Delivery Reviews·Jeffrey J Lochhead, Robert G Thorne
Dec 15, 2011·Pharmaceutical Research·Qingfeng LiuXinguo Jiang
Mar 21, 2012·Nature Reviews. Neuroscience·Ana M Fernandez, Ignacio Torres-Alemán
Apr 14, 2012·Journal of Aging Research·Ana I DuarteCatarina R Oliveira
Jul 24, 2012·Pharmacology & Therapeutics·William A BanksMichelle A Erickson
Mar 15, 2013·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Per G DjupeslandJohn C Messina
Apr 17, 2013·Expert Opinion on Drug Delivery·Chandrakantsing Vijaysing Pardeshi, Veena Shailendra Belgamwar
Mar 13, 2014·Drugs & Aging·Tiago Martins RodriguesMaria José Diógenes
Nov 26, 2014·Neural Regeneration Research·Shane V HegartyAideen M Sullivan
Dec 3, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Noriyasu Kamei, Mariko Takeda-Morishita
Jul 15, 2015·Current Alzheimer Research·Lindsay J SpielmanAndis Klegeris

❮ Previous
Next ❯

Citations

Apr 12, 2016·Frontiers in Aging Neuroscience·Juhyun Song, Jongpil Kim
Mar 9, 2018·Frontiers in Neuroscience·Liying YangAnmu Xie
Feb 24, 2019·Scientific Reports·Jeffrey J LochheadThomas P Davis
Feb 15, 2019·Neural Regeneration Research·Lir-Wan FanYi Pang
Sep 3, 2019·Frontiers in Neuroscience·Francesca FioryFrancesco Oriente
Feb 23, 2020·Journal of Diabetes Research·Yanan SunXu He
Dec 4, 2019·Frontiers in Aging Neuroscience·Domenico SergiMaria-Grazia Martinoli
Jan 27, 2021·CNS Neuroscience & Therapeutics·Farideh IravanpourAbolhassan Ahmadiani
Jan 26, 2021·Drug Delivery and Translational Research·Lea-Adriana KellerAndreas Popp
Jan 31, 2021·CNS Drugs·Manfred Hallschmid
Oct 27, 2020·Frontiers in Neuroscience·Michael ShaughnessKimberly R Byrnes
Apr 2, 2021·Frontiers in Neuroscience·Athira AnirudhanShiek S S J Ahmed
Nov 14, 2017·Neuropharmacology·Marcelo N N VieiraFernanda G De Felice
Apr 29, 2021·Neural Regeneration Research·Xue ZhangAn-Mu Xie
May 1, 2021·International Journal of Molecular Sciences·Sara Al Hussein Al AwamlhDavid J Calkins
Aug 13, 2021·Neural Regeneration Research·Angela De IuliisCarlo Colosimo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.